$BGMD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BG Medicine, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BG Medicine, Inc.. Get notifications about new insider transactions in BG Medicine, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2013 | BGMD | BG Medicine, Inc. | Harris Timothy J.R. | Director | Option Exercise | A | 1.68 | 4,205 | 7,064 | 4,205 | |
Jun 14 2013 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 1.68 | 4,205 | 7,064 | 4,205 | |
Jun 14 2013 | BGMD | BG Medicine, Inc. | Posner Brian S | Director | Option Exercise | A | 1.68 | 4,205 | 7,064 | 4,205 | |
May 14 2013 | BGMD | BG Medicine, Inc. | SOHMER PAUL R | President & CEO | Option Exercise | A | 1.67 | 700,000 | 1,169,000 | 700,000 | |
May 03 2013 | BGMD | BG Medicine, Inc. | Bancel Stephane | Executive Chairman | Option Exercise | A | 1.61 | 39,473 | 63,552 | 39,473 | |
Apr 30 2013 | BGMD | BG Medicine, Inc. | Rader Anastasia | SVP, Executive Oper ... | Option Exercise | A | 1.69 | 75,000 | 126,750 | 75,000 | |
Apr 30 2013 | BGMD | BG Medicine, Inc. | Adourian Aram S. | SVP & Chief Scienti ... | Option Exercise | A | 1.69 | 200,000 | 338,000 | 200,000 | |
Feb 01 2013 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | P | 2.00 | 1,050,000 | 2,100,000 | 1,764,286 | 714.3 K to 1.8 M (+147.00 %) |
Feb 01 2013 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | P | 2.00 | 500,000 | 1,000,000 | 2,851,447 | 2.4 M to 2.9 M (+21.26 %) |
Feb 01 2013 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | P | 2.00 | 75,000 | 150,000 | 215,013 | 140 K to 215 K (+53.57 %) |
Feb 01 2013 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | P | 2.00 | 125,000 | 250,000 | 651,560 | 526.6 K to 651.6 K (+23.74 %) |
Feb 01 2013 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | P | 2.00 | 250,000 | 500,000 | 2,434,800 | 2.2 M to 2.4 M (+11.44 %) |
Feb 01 2013 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | P | 2.00 | 250,000 | 500,000 | 1,187,713 | 937.7 K to 1.2 M (+26.66 %) |
Dec 12 2012 | BGMD | BG Medicine, Inc. | Abdalian Charles H Jr | EVP & Chief Financi ... | Option Exercise | A | 1.33 | 140,000 | 186,200 | 140,000 | |
Nov 20 2012 | BGMD | BG Medicine, Inc. | Posner Brian S | Director | Buy | P | 1.17 | 10,000 | 11,650 | 20,000 | 10 K to 20 K (+100.00 %) |
Nov 19 2012 | BGMD | BG Medicine, Inc. | Bancel Stephane | Executive Chairman | Buy | P | 1.26 | 100,000 | 126,000 | 123,167 | 23.2 K to 123.2 K (+431.65 %) |
Oct 09 2012 | BGMD | BG Medicine, Inc. | Adourian Aram S. | SVP & Chief Scienti ... | Option Exercise | A | 3.61 | 40,000 | 144,400 | 40,000 | |
Sep 17 2012 | BGMD | BG Medicine, Inc. | Bancel Stephane | Executive Chairman | Buy | P | 3.70 | 1,381 | 5,110 | 23,167 | 21.8 K to 23.2 K (+6.34 %) |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | X | 0.02 | 6,422 | 128 | 0 | |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | X | 0.02 | 6,422 | 128 | 0 | |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | X | 0.02 | 6,422 | 128 | 0 | |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | X | 0.03 | 2,353 | 71 | 0 | |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Sell | J | 0.00 | 298,137 | 0 | 0 | 298.1 K to 0 (-100.00 %) |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Sell | S | 5.83 | 23 | 134 | 298,137 | 298.2 K to 298.1 K (-0.01 %) |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | X | 0.02 | 6,422 | 128 | 298,160 | 291.7 K to 298.2 K (+2.20 %) |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Sell | S | 5.83 | 23 | 134 | 291,738 | 291.8 K to 291.7 K (-0.01 %) |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | X | 0.02 | 6,422 | 128 | 291,761 | 285.3 K to 291.8 K (+2.25 %) |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Sell | S | 5.83 | 23 | 134 | 285,339 | 285.4 K to 285.3 K (-0.01 %) |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | X | 0.02 | 6,422 | 128 | 285,362 | 278.9 K to 285.4 K (+2.30 %) |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Sell | S | 5.83 | 13 | 76 | 278,940 | 279 K to 278.9 K (0.00 %) |
Aug 22 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | X | 0.03 | 2,353 | 71 | 278,953 | 276.6 K to 279 K (+0.85 %) |
Aug 10 2012 | BGMD | BG Medicine, Inc. | Densel William | General Manager, Ca ... | Option Exercise | A | 6.90 | 100,000 | 690,000 | 100,000 | |
Jun 13 2012 | BGMD | BG Medicine, Inc. | Harris Timothy J.R. | Director | Option Exercise | A | 5.69 | 4,205 | 23,926 | 4,205 | |
Jun 13 2012 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 5.69 | 4,205 | 23,926 | 4,205 | |
Jun 13 2012 | BGMD | BG Medicine, Inc. | BAINS HARRISON M JR | Director | Option Exercise | A | 5.69 | 4,205 | 23,926 | 4,205 | |
Jun 13 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | A | 5.69 | 4,205 | 23,926 | 4,205 | |
Jun 11 2012 | BGMD | BG Medicine, Inc. | Muntendam Pieter | EVP, Chief Medical ... | Sell | S | 5.29 | 3,965 | 20,975 | 78,483 | 82.4 K to 78.5 K (-4.81 %) |
Jun 11 2012 | BGMD | BG Medicine, Inc. | Muntendam Pieter | EVP, Chief Medical ... | Sell | S | 5.50 | 30,021 | 165,116 | 82,448 | 112.5 K to 82.4 K (-26.69 %) |
Jun 01 2012 | BGMD | BG Medicine, Inc. | Muntendam Pieter | EVP, Chief Medical ... | Option Exercise | M | 0.90 | 100,000 | 90,000 | 82,239 | |
Jun 01 2012 | BGMD | BG Medicine, Inc. | Muntendam Pieter | EVP, Chief Medical ... | Buy | M | 0.90 | 100,000 | 90,000 | 112,469 | 12.5 K to 112.5 K (+801.99 %) |
May 24 2012 | BGMD | BG Medicine, Inc. | Bouvier Eric | President, CEO | Buy | P | 3.95 | 10,000 | 39,500 | 10,000 | 0 to 10 K |
May 23 2012 | BGMD | BG Medicine, Inc. | Posner Brian S | Director | Buy | P | 4.04 | 10,000 | 40,400 | 10,000 | 0 to 10 K |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | X | 0.02 | 7,001 | 140 | 0 | |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | X | 0.02 | 7,001 | 140 | 0 | |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | X | 0.02 | 7,001 | 140 | 0 | |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | X | 0.02 | 2,580 | 52 | 0 | |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | X | 0.03 | 2,497 | 75 | 0 | |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Sell | J | 0.00 | 130,867 | 0 | 0 | 130.9 K to 0 (-100.00 %) |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Sell | S | 3.95 | 36 | 142 | 130,867 | 130.9 K to 130.9 K (-0.03 %) |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | X | 0.02 | 7,001 | 140 | 130,903 | 123.9 K to 130.9 K (+5.65 %) |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Sell | S | 3.95 | 36 | 142 | 123,902 | 123.9 K to 123.9 K (-0.03 %) |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | X | 0.02 | 7,001 | 140 | 123,938 | 116.9 K to 123.9 K (+5.99 %) |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Sell | S | 3.95 | 36 | 142 | 116,937 | 117 K to 116.9 K (-0.03 %) |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | X | 0.02 | 7,001 | 140 | 116,973 | 110 K to 117 K (+6.37 %) |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Sell | S | 3.95 | 14 | 55 | 109,972 | 110 K to 110 K (-0.01 %) |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | X | 0.02 | 2,580 | 52 | 109,986 | 107.4 K to 110 K (+2.40 %) |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Sell | S | 3.95 | 19 | 75 | 107,406 | 107.4 K to 107.4 K (-0.02 %) |
May 23 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Buy | X | 0.03 | 2,497 | 75 | 107,425 | 104.9 K to 107.4 K (+2.38 %) |
May 21 2012 | BGMD | BG Medicine, Inc. | Bancel Stephane | Executive Chairman | Buy | P | 3.84 | 5,008 | 19,231 | 21,786 | 16.8 K to 21.8 K (+29.85 %) |
Apr 19 2012 | BGMD | BG Medicine, Inc. | van der Meer Pieter | 10% Owner | Sell | S | 6.60 | 200,000 | 1,320,000 | 1,635,432 | 1.8 M to 1.6 M (-10.90 %) |
Mar 21 2012 | BGMD | BG Medicine, Inc. | Adourian Aram S. | VP, Scientific Affa ... | Option Exercise | M | 0.90 | 7,009 | 6,308 | 0 | |
Mar 21 2012 | BGMD | BG Medicine, Inc. | Adourian Aram S. | VP, Scientific Affa ... | Buy | M | 0.90 | 7,009 | 6,308 | 28,036 | 21 K to 28 K (+33.33 %) |
Feb 29 2012 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 7.78 | 4,205 | 32,715 | 4,205 | |
Feb 29 2012 | BGMD | BG Medicine, Inc. | Harris Timothy J.R. | Director | Option Exercise | A | 7.78 | 4,205 | 32,715 | 4,205 | |
Feb 29 2012 | BGMD | BG Medicine, Inc. | Bancel Stephane | Executive Chairman | Option Exercise | A | 7.78 | 4,205 | 32,715 | 4,205 | |
Feb 29 2012 | BGMD | BG Medicine, Inc. | BAINS HARRISON M JR | Director | Option Exercise | A | 7.78 | 4,205 | 32,715 | 4,205 | |
Feb 29 2012 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | A | 7.78 | 4,205 | 32,715 | 4,205 | |
Feb 24 2012 | BGMD | BG Medicine, Inc. | Bancel Stephane | Executive Chairman | Buy | P | 0.00 | 2,778 | 0 | 16,778 | 14 K to 16.8 K (+19.84 %) |
Feb 24 2012 | BGMD | BG Medicine, Inc. | Rader Anastasia | SVP, Executive Oper ... | Option Exercise | A | 7.84 | 30,000 | 235,200 | 30,000 | |
Feb 24 2012 | BGMD | BG Medicine, Inc. | Adourian Aram S. | VP, Scientific Affa ... | Option Exercise | A | 7.84 | 40,000 | 313,600 | 40,000 | |
Feb 24 2012 | BGMD | BG Medicine, Inc. | GORDON NEAL | SVP, Biomarker Disc ... | Option Exercise | A | 7.84 | 30,000 | 235,200 | 30,000 | |
Feb 24 2012 | BGMD | BG Medicine, Inc. | Miller Stephen R. | Chief Commercial Of ... | Option Exercise | A | 7.84 | 30,000 | 235,200 | 30,000 | |
Feb 24 2012 | BGMD | BG Medicine, Inc. | ROGERS MICHAEL W | EVP, CFO and Treasu ... | Option Exercise | A | 7.84 | 35,000 | 274,400 | 35,000 | |
Feb 15 2012 | BGMD | BG Medicine, Inc. | Posner Brian S | Director | Option Exercise | A | 8.27 | 8,410 | 69,551 | 8,410 | |
Jan 11 2012 | BGMD | BG Medicine, Inc. | Bouvier Eric | President, CEO | Option Exercise | A | 5.17 | 725,675 | 3,751,740 | 725,675 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | X | 0.02 | 5,773 | 115 | 0 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | X | 0.02 | 5,773 | 115 | 0 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | X | 0.02 | 5,773 | 115 | 0 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | X | 0.02 | 7,243 | 145 | 0 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | X | 0.03 | 1,833 | 55 | 0 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | X | 0.03 | 3,667 | 110 | 0 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | X | 0.03 | 1,833 | 55 | 0 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | X | 0.03 | 1,833 | 55 | 0 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | X | 0.03 | 1,833 | 55 | 0 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | X | 0.03 | 1,833 | 55 | 0 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | X | 0.03 | 20,767 | 623 | 0 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | X | 0.03 | 93,455 | 2,804 | 0 | |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Sell | S | 4.01 | 29 | 116 | 937,713 | 937.7 K to 937.7 K (0.00 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | X | 0.02 | 5,773 | 115 | 937,742 | 932 K to 937.7 K (+0.62 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Sell | S | 4.01 | 29 | 116 | 931,969 | 932 K to 932 K (0.00 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | X | 0.02 | 5,773 | 115 | 931,998 | 926.2 K to 932 K (+0.62 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Sell | S | 4.01 | 29 | 116 | 926,225 | 926.3 K to 926.2 K (0.00 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | X | 0.02 | 5,773 | 115 | 926,254 | 920.5 K to 926.3 K (+0.63 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Sell | S | 4.01 | 37 | 148 | 920,481 | 920.5 K to 920.5 K (0.00 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | X | 0.02 | 7,243 | 145 | 920,518 | 913.3 K to 920.5 K (+0.79 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Sell | S | 4.01 | 14 | 56 | 913,275 | 913.3 K to 913.3 K (0.00 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | X | 0.03 | 1,833 | 55 | 913,289 | 911.5 K to 913.3 K (+0.20 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Sell | S | 4.01 | 28 | 112 | 911,456 | 911.5 K to 911.5 K (0.00 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | X | 0.03 | 3,667 | 110 | 911,484 | 907.8 K to 911.5 K (+0.40 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Sell | S | 4.01 | 14 | 56 | 907,817 | 907.8 K to 907.8 K (0.00 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | X | 0.03 | 1,833 | 55 | 907,831 | 906 K to 907.8 K (+0.20 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Sell | S | 4.01 | 14 | 56 | 905,998 | 906 K to 906 K (0.00 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | X | 0.03 | 1,833 | 55 | 906,012 | 904.2 K to 906 K (+0.20 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Sell | S | 4.01 | 14 | 56 | 904,179 | 904.2 K to 904.2 K (0.00 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | X | 0.03 | 1,833 | 55 | 904,193 | 902.4 K to 904.2 K (+0.20 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Sell | S | 4.01 | 14 | 56 | 902,360 | 902.4 K to 902.4 K (0.00 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | X | 0.03 | 1,833 | 55 | 902,374 | 900.5 K to 902.4 K (+0.20 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Sell | S | 4.01 | 156 | 626 | 900,541 | 900.7 K to 900.5 K (-0.02 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | X | 0.03 | 20,767 | 623 | 900,697 | 879.9 K to 900.7 K (+2.36 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Sell | S | 4.01 | 700 | 2,807 | 879,930 | 880.6 K to 879.9 K (-0.08 %) |
Dec 01 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | X | 0.03 | 93,455 | 2,804 | 880,630 | 787.2 K to 880.6 K (+11.87 %) |
Nov 14 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 0.90 | 336,441 | 302,797 | 0 | |
Nov 14 2011 | BGMD | BG Medicine, Inc. | PAPADOPOULOS STELIOS | Director | Buy | M | 0.90 | 336,441 | 302,797 | 787,175 | 450.7 K to 787.2 K (+74.64 %) |
Sep 20 2011 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Sell | J | 0.00 | 193,133 | 0 | 104,928 | 298.1 K to 104.9 K (-64.80 %) |
Jul 27 2011 | BGMD | BG Medicine, Inc. | Bancel Stephane | Executive Chairman | Option Exercise | A | 8.11 | 235,390 | 1,909,013 | 235,390 | |
Sep 12 2011 | BGMD | BG Medicine, Inc. | Bancel Stephane | Executive Chairman | Buy | P | 3.63 | 6,000 | 21,767 | 14,000 | 8 K to 14 K (+75.00 %) |
Sep 12 2011 | BGMD | BG Medicine, Inc. | Bancel Stephane | Executive Chairman | Buy | P | 4.30 | 4,000 | 17,200 | 8,000 | 4 K to 8 K (+100.00 %) |
Sep 12 2011 | BGMD | BG Medicine, Inc. | Bancel Stephane | Executive Chairman | Buy | P | 4.40 | 4,000 | 17,600 | 4,000 | 0 to 4 K |
Sep 06 2011 | BGMD | BG Medicine, Inc. | Muntendam Pieter | President, CEO | Option Exercise | X | 0.03 | 2,803 | 84 | 0 | |
Sep 06 2011 | BGMD | BG Medicine, Inc. | Muntendam Pieter | President, CEO | Sell | S | 6.29 | 14 | 88 | 12,469 | 12.5 K to 12.5 K (-0.11 %) |
Sep 06 2011 | BGMD | BG Medicine, Inc. | Muntendam Pieter | President, CEO | Buy | X | 0.03 | 2,803 | 84 | 12,483 | 9.7 K to 12.5 K (+28.96 %) |
Jul 01 2011 | BGMD | BG Medicine, Inc. | Rader Anastasia | SVP, Executive Oper ... | Option Exercise | A | 7.96 | 26,651 | 212,142 | 26,651 | |
Jul 01 2011 | BGMD | BG Medicine, Inc. | Adourian Aram S. | VP, Scientific Affa ... | Option Exercise | A | 7.96 | 32,417 | 258,039 | 32,417 | |
Jul 01 2011 | BGMD | BG Medicine, Inc. | GORDON NEAL | SVP, Biomarker Disc ... | Option Exercise | A | 7.96 | 27,233 | 216,775 | 27,233 | |
Jul 01 2011 | BGMD | BG Medicine, Inc. | ROGERS MICHAEL W | EVP, CFO and Treasu ... | Option Exercise | A | 7.96 | 75,598 | 601,760 | 75,598 | |
Jul 01 2011 | BGMD | BG Medicine, Inc. | Muntendam Pieter | President, CEO | Option Exercise | A | 7.96 | 162,995 | 1,297,440 | 162,995 | |
Jul 01 2011 | BGMD | BG Medicine, Inc. | Miller Stephen R. | Chief Commercial Of ... | Option Exercise | A | 7.96 | 125,000 | 995,000 | 125,000 | |
Mar 04 2011 | BGMD | BG Medicine, Inc. | Shepherd Wayne K. | VP, Sales and Marke ... | Option Exercise | A | 8.70 | 29,999 | 260,991 | 29,999 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | van der Meer Pieter | Director | Option Exercise | P | 0.02 | 23,080 | 462 | 23,080 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | van der Meer Pieter | Director | Option Exercise | P | 0.02 | 23,080 | 462 | 23,080 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | van der Meer Pieter | Director | Option Exercise | C | 0.00 | 366,809 | 0 | 0 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | van der Meer Pieter | Director | Option Exercise | C | 0.00 | 4,711,820 | 0 | 0 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | van der Meer Pieter | Director | Buy | P | 7.00 | 142,857 | 999,999 | 1,835,432 | 1.7 M to 1.8 M (+8.44 %) |
Feb 11 2011 | BGMD | BG Medicine, Inc. | van der Meer Pieter | Director | Buy | C | 7.00 | 151,450 | 1,060,150 | 1,692,575 | 1.5 M to 1.7 M (+9.83 %) |
Feb 11 2011 | BGMD | BG Medicine, Inc. | van der Meer Pieter | Director | Buy | C | 0.00 | 1,541,125 | 0 | 1,541,125 | 0 to 1.5 M |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AGTC Partners, L.P. | 10% Owner | Option Exercise | P | 0.02 | 6 | 0 | 6 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AGTC Partners, L.P. | 10% Owner | Option Exercise | P | 0.02 | 6 | 0 | 6 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AGTC Partners, L.P. | 10% Owner | Option Exercise | C | 0.00 | 630,026 | 0 | 0 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AGTC Partners, L.P. | 10% Owner | Option Exercise | C | 0.00 | 38,083 | 0 | 0 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AGTC Partners, L.P. | 10% Owner | Option Exercise | C | 0.00 | 6,070,468 | 0 | 0 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AGTC Partners, L.P. | 10% Owner | Option Exercise | C | 0.00 | 366,933 | 0 | 0 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AGTC Partners, L.P. | 10% Owner | Buy | P | 7.00 | 271,429 | 1,900,003 | 2,351,447 | 2.1 M to 2.4 M (+13.05 %) |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AGTC Partners, L.P. | 10% Owner | Buy | C | 7.00 | 43 | 301 | 2,080,018 | 2.1 M to 2.1 M (0.00 %) |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AGTC Partners, L.P. | 10% Owner | Buy | C | 0.00 | 2,079,975 | 0 | 2,079,975 | 0 to 2.1 M |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AGTC Partners, L.P. | 10% Owner | Buy | P | 7.00 | 14,285 | 99,995 | 140,013 | 125.7 K to 140 K (+11.36 %) |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AGTC Partners, L.P. | 10% Owner | Buy | C | 7.00 | 3 | 21 | 125,728 | 125.7 K to 125.7 K (0.00 %) |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AGTC Partners, L.P. | 10% Owner | Buy | C | 0.00 | 125,725 | 0 | 125,725 | 0 to 125.7 K |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | P | 0.02 | 46,142 | 923 | 46,142 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | P | 0.02 | 46,142 | 923 | 46,142 | |
Feb 11 2011 | BGMD | BG Medicine, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 630,026 | 0 | 0 |